Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ertan Saracbasi‐Zender"'
Autor:
Dietmar Krause, Anna Mai, Renate Klaassen‐Mielke, Nina Timmesfeld, Ulrike Trampisch, Henrik Rudolf, Xenofon Baraliakos, Elmar Schmitz, Claas Fendler, Claudia Klink, Stephanie Boeddeker, Ertan Saracbasi‐Zender, Hans‐Joachim Christoph, Manfred Igelmann, Hans‐Juergen Menne, Albert Schmid, Rolf Rau, Siegfried Wassenberg, Nilüfer Sonuc, Claudia Ose, Carmen Schade‐Brittinger, Hans J. Trampisch, Juergen Braun
Publikováno v:
Arthritis & Rheumatology. 74:1628-1637
The structured delegation of medical care services for patients with inflammatory rheumatic diseases
Autor:
Dietmar Krause, Anna Mai, Robin Denz, Johannes Johow, Jens-Peter Reese, Benjamin Westerhoff, Renate Klaaßen-Mielke, Nina Timmesfeld, Annette Rittstieg, Ertan Saracbasi-Zender, Judith Günzel, Claudia Klink, Elmar Schmitz, Claas Fendler, Wolf Raub, Stephanie Böddeker, Friedrich Dybowski, Georg Hübner, Hans-Jürgen Menne, Heinz-Jürgen Lakomek, Michael Sarholz, Ulrike Trampisch, Hans J. Trampisch, Jürgen Braun
Publikováno v:
Deutsches Ärzteblatt international.
Autor:
Dietmar, Krause, Anna, Mai, Renate, Klaassen-Mielke, Nina, Timmesfeld, Ulrike, Trampisch, Henrik, Rudolf, Xenofon, Baraliakos, Elmar, Schmitz, Claas, Fendler, Claudia, Klink, Stephanie, Boeddeker, Ertan, Saracbasi-Zender, Hans-Joachim, Christoph, Manfred, Igelmann, Hans-Juergen, Menne, Albert, Schmid, Rolf, Rau, Siegfried, Wassenberg, Nilüfer, Sonuc, Claudia, Ose, Carmen, Schade-Brittinger, Hans J, Trampisch, Juergen, Braun
Objective: In active early rheumatoid arthritis (RA), glucocorticoids are often used for bridging, due to the delayed action of methotrexate. This study was undertaken to compare the effect of 3 bridging strategies, including high-dose and low-dose p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ce192f29401a40bdcc4b5184c3f45f74
https://www.ncbi.nlm.nih.gov/pubmed/35643951
https://www.ncbi.nlm.nih.gov/pubmed/35643951
Autor:
Ertan Saracbasi-Zender, Elmar Schmitz-Bortz, Jürgen Braun, Xenofon Baraliakos, Hans-Jürgen Menne, Friedrich Dybowski, Uta Kiltz, Manfred Igelmann, Andrea Regel, Ludwig Kalthoff, Dietmar Krause
Publikováno v:
Rheumatology. 57:1541-1547
Background The Assessments of Spondyloarthritis international Society (ASAS) classification criteria for axial spondyloarthritis (axSpA) have been criticized because of insufficient differentiation towards FM. The aim of this study was to compare the
Autor:
Dietmar Krause, Mathura Vigneswaran, Elmar Schmitz-Bortz, Juergen Braun, Hans-Juergen Menne, Uta Kiltz, Friedrich Dybowski, Xenofon Baraliakos, Manfred Igelmann, Ludwig Kalthoff, Ertan Saracbasi-Zender, Soeren A. Peters, Heiner Appel
Publikováno v:
Rheumatology (Oxford, England). 56(1)
Objective NSAIDs are first-line therapy in axial SpA (axSpA). The proportion of patients responding to NSAIDs and differences between AS and non-radiographic axSpA (nr-axSpA) in this regard have not been studied in detail to date. The aim of this stu
Publikováno v:
Current Rheumatology Reports. 12:325-331
Axial spondyloarthritis, which includes ankylosing spondylitis and psoriatic spondyloarthritis, is an important subtype of the spondyloarthritides. Tumor necrosis factor (TNF) antagonists are effective therapies for this partially heterogeneous group